Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

GLIMEPIRIDE 4 MG TABLET

glimepiride
$0.0472per EA

Strength

4 mg/1

Manufacturer

Solco Healthcare US LLC

NDC

43547039650

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

GLIMEPIRIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077370

On Market Since

1/30/2017

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price History

1W

0.0%

1M

+10.1%

3M

+23.5%

6M

+5.1%

1Y

+30.5%

3Y

+2.7%

5Y

-12.9%

All

-55.0%

Generic Alternatives

1 alternative • Same active ingredient

GLIMEPIRIDE 4 MG TABLET
Generic
43547039610•Solco Healthcare US LLC
$0.0472

Related Drugs

Same classification

GLIMEPIRIDE 1 MG TABLET
Generic
16571077301•Rising Pharma Holdings Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
16571077350•Rising Pharma Holdings Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
16729000116•Accord Healthcare Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
42571010001•Micro Labs Limited
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
50268035815•AvPAK
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
55111032001•Dr. Reddy's Laboratories Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
55111032005•Dr. Reddy's Laboratories Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
61442011501•Carlsbad Technology Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
61442011505•Carlsbad Technology Inc.
$0.0225
per EA
GLIMEPIRIDE 1 MG TABLET
Generic
68001058400•BluePoint Laboratories
$0.0225
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy